Dongwei Xu
- Molecular Biology
- Epidemiology top 10%
- Immunology top 10%
- Surgery
- Hepatology top 5%
- Topics
- Autophagy in Disease and Therapy (6 papers)Genomics, phytochemicals, and oxidative stress (5 papers)MicroRNA in disease regulation (5 papers)
- Cited by
- HepatologyPharmacologyImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dongwei Xu
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 516
- Epidemiology 318
- Immunology 237
- Surgery 193
- Hepatology 188
Countries citing papers authored by Dongwei Xu
This map shows the geographic impact of Dongwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Xu more than expected).
Fields of papers citing papers by Dongwei Xu
This network shows the impact of papers produced by Dongwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Xu. The network helps show where Dongwei Xu may publish in the future.
Co-authorship network of co-authors of Dongwei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Xu. A scholar is included among the top collaborators of Dongwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Xu. Dongwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | 8 | |
| 6 | 29 | |
| 7 | 4 | |
| 8 | 16 | |
| 9 | 13 | |
| 10 | 8 | |
| 11 | 19 | |
| 12 | 26 | |
| 13 | 8 | |
| 14 | 8 | |
| 15 | 33 | |
| 16 | 7 | |
| 17 | 18 | |
| 18 | 106 | |
| 19 | 4 | |
| 20 | 22 |
About Dongwei Xu
Dongwei Xu is a scholar working on Hepatology, Nephrology and Cancer Research, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Hepatology (188 citations), Pharmacology (109 citations) and Immunology (237 citations). Dongwei Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qiang Xia, Xiaoni Kong, Hailong Wu, Bibo Ke, Min Xu, Seogsong Jeong, Yizhu Tian, Yihan Qian, Mingwei Sheng and Douglas G. Farmer. Their work appears in journals such as Hepatology, Scientific Reports and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.